Medicare AdvantageAdministrativeLow impact
[Virginia] Enhancing care for peri- and postmenopausal women: addressing recurrent UTIs with vaginal estrogen therapy
Anthem BCBS·VA · Urology, OB-GYN, Geriatrics +2 more·Provider Bulletin
Effective date
Aug 1, 2026
We identified it
Aug 2, 2026
Summary
Anthem Blue Cross and Blue Shield (Virginia) issued an educational bulletin promoting vaginal estrogen therapy as a recommended treatment for recurrent UTIs in peri- and postmenopausal women, aligned with AUA clinical guidelines. This is an informational policy update to encourage provider awareness and patient counseling rather than a billing or coverage rule change.
Action Required
No billing workflow changes required. This is an educational bulletin, not a coverage or authorization policy change. Providers may distribute the included AUA resources to eligible patients and document discussions about vaginal estrogen therapy in clinical notes. Billing and prior authorization processes remain unchanged. No deadline or compliance requirement is specified.